CytomX stock rockets 35% after deal with Amgen MarketWatch By John Harbison|2017-10-04T12:42:28-08:00October 4, 2017|Tech Coast Angels Portfolio Companies in the Press|Comments Off on CytomX stock rockets 35% after deal with Amgen Share This Story, Choose Your Platform! FacebookTwitterRedditLinkedInWhatsAppTumblrPinterestVkXingEmail About the Author: John Harbison Related Posts
